Lung cancer has the highest mortality rate of all cancers and one of the worst five year survival rates of all cancers at 17% for men and 22% for women. What makes lung cancer so deadly is that the symptoms are non-specific, and patients often only come to the clinic when tumors have exceeded a critical size or when cancer cells have attacked the lymph nodes or have metastasized. The only chance of a cure is to diagnose lung cancer as early as possible. Early detection and the introduction of screening programs have the potential to fundamentally improve lung cancer healthcare. Although treatment for advanced tumor stages, such as immunotherapy, works well, it is also very expensive and a significant burden for the healthcare system. The cost per life saved by a screening program is therefore much lower.
Find out more about the benefits of lung cancer screening and its life-saving potential
Artificial intelligence – a second pair of eyes for the radiologist
Other screening programs were heavily pushed and promoted by the patient organizations. It’s different for lung cancer, and the reason is very sad: patient organizations mainly comprise survivors; in lung cancer, we don't have so many survivors. But more and more frequently, medical and scientific organizations have started to promote screening for the benefit of their patients.Sebastian Schmidt, MD, Head of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers
Large-scale screening is only organized in three European countries: Croatia, Poland and the U.K. Only about 2% of the European population has access to lung screening. There are some private initiatives in some countries, but in general it’s quite limited and uncoordinated.Marie-Pierre Revel, Professor of Radiology and Head of the Radiology Department at Cochin Hospital, Université de Paris, France
The devices that we are now using are so low in radiation that I see no risk to those facing an examination.
Prof. Felix Herth, Head of the Heidelberg University Hospital Thoraxklinik, Germany
Why screening is so important
We ask ourselves what to say to patients who stopped smoking 20 years ago and who develop lung cancer. Should we tell them: If you had continued smoking, you would have been screened?”Barbara Baysal, German Self-Help Lung Cancer Association (Bundesverband Selbsthilfe Lungenkrebs e.V.)
We now have eight large, randomized studies and masses of real-world data, mainly from the USA. We have a clear recommendation from the professional societies and the guidelines and a positive vote from the Institute for Quality and Efficiency in Health Care IQWiG. We will not get any more evidence.Prof. Dr. Jens Vogel-Claussen, Deputy Director, Institute for Diagnostic and Interventional Radiology, Hannover Medical School
Treatment of lung cancer
Depending on the stage and cancer type, the treatment could be surgery, chemo, radiation or immunotherapy. With the introduction of lung cancer screening, more cases are expected to be discovered in an earlier stage. Therefore, the current therapy mix of surgery, radiation therapy and chemotherapy will probably change to less invasive methods where imaging might also play a bigger role. Key-hole surgery, stereotactic radiation therapy and local ablation techniques and combinations may become more important.
A joint effort to empower personalized cancer care
Thoracic procedures with hybrid OR imaging solutions
Lung imaging with photon-counting CT
We’re able to visualize changes in the thin septa, the trachea and the bronchial walls that were previously invisible to us.Professor Heinz-Peter Schlemmer, MD, Head of Radiology, German Cancer Research Center (DKFZ), Heidelberg
What does the future of cancer care look like?
Learn how the digital twin of the patient could lead to early detection of cancer in the future using AI technology and medical expertise. Health data integration could enable personalized care even before hospitalization to achieve the best possible patient-reported outcomes.
 https://www.krebsdaten.de/Krebs/EN/Content/Cancer_sites/Lung_cancer/lung_cancer_node.html (Accessed Nov 2022)
The statements by Siemens Healthineers customers/institutions described herein are based on results that were achieved in the customer’s or institutions' unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers/institutions will achieve the same results.
Not all products/features are commercially available in all countries. Their future availability cannot be ensured.
Several devices of AI-Rad Companion are planned and under development, not commercially available in all countries, and their future availability cannot be ensured. Please contact your local Siemens Healthineers organization for further details.
The Digital Twin video describes future ideas and concepts. It is not intended to describe specific performance and/or safety characteristics of currently planned or future products. Future realization and availability cannot be guaranteed. Names of persons are fictious; any similarities are purely coincidental.
Digital Twin is currently under development; it is not for sale in the U.S.A. Its future availability cannot be guaranteed.